4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001780081-25-000004
Director sold 40,472 shares at an average $26.98 ($1,092,058)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Krainer Adrian R. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-14 | Sale : show line 1 in the form 10b5-1 | −19,790 | $26.61 | $526,693 | 384,928 | D |
| 2025-11-14 | Sale : show line 2 in the form 10b5-1 | −20,682 | $27.34 | $565,365 | 364,246 | D |
| Open-market sales · 40,472 sh · avg $26.98 · $1,092,058 | ||||||
Loading xslF345X05/form4-11182025_091122.xml…